The fastest way to find evidence, explore hidden connections and create new hypotheses

Looking for a smarter way to identify new targets?

Watch Causaly’s webinar with Roche discussing AI for smarter portfolio management.

In this on-demand webinar Ivan John Clement, previous R&D Portfolio Data Strategy Lead from Roche and Yiannis Kiachopoulos, CEO of Causaly discuss how:

Roche is partnering with Causaly to build a unified and systematic approach to drive better project and portfolio level decisions.
A user-centric application of AI for smarter portfolio management leads to value creation in early R&D.
Causaly’s machine-reading algorithms truly understand text like a human does, allowing Roche and other users to receive simple answers to complex questions within seconds.

Trusted by world-leading organizations

Use cases and projects

Target identification/Validation
Biomarker discovery
Drug repurposing, indication expansion
Outcomes research, RWE
Safety profiling
Medical affairs

Trusted by world leading organizations

Founded in 2018, Causaly’s mission is to transform how humans can find, visualize and interpret biomedical knowledge, to accelerate solutions for some of the greatest challenges we face in human health. Causaly acts as an operating system for biomedical and health data that empowers researchers to effortlessly identify new research avenues and innovative drug development opportunities. Its technology mimics human reading, and digests tens of millions of documents into an Enterprise Knowledge Graph allowing researchers and decision-makers to answer questions they can’t answer anywhere else.

Learn More

The fastest way to find evidence, explore hidden connections and create new hypotheses

Looking for a smarter way to identify new targets?

Trusted by world-leading organizations

Use cases and projects

Trusted by world leading organizations

Request access to the webinar

About us

LinkedIn